Newsletter | June 9, 2026

06.09.26 -- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders

FEATURED EDITORIAL

U.S. Policy Drift And The Shift In Clinical Trial Supply Leadership

China's clinical trial system now outpaces the U.S., exposing regulatory delays that ripple into supply planning, manufacturing windows, and drug development speed. 

Real-World Data Is Reshaping How We Supply Clinical Trials

Real-world data is increasingly transforming clinical trial supply planning by improving forecasting accuracy, reducing waste, and enabling faster, leaner, and more efficient trials at scale.

Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders

Equip your clinical supply team with the tools and strategies needed to manage both on-site and remote audits with confidence — turning inspection findings into stronger, more resilient systems.
 

INDUSTRY INSIGHTS

The Pharmacy Advantage In Direct-To-Patient Clinical Supply

Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.

SOLUTIONS

The Shift Toward Self-Administration And Integrated Supply Chains